Paxman

The Paxman Scalp Cooling System has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The concept behind the system came when the mother of four, Sue Paxman, experienced first-hand the trauma of chemotherapy-induced hair loss. With close to 3,500 systems delivered in to hospitals, clinics and treatment centres around the world, PAXMAN is the leading supplier of Scalp Cooling technology.

CIA compromises patient quality of life, can negatively impact on body image, self-esteem and deprive patients of their privacy.  Sometimes, the prospect of CIA can cause patients to refuse treatment.

Scalp cooling is proven to be an effective way of combatting CIA and can result in a high level of retention or completely preserve the hair. For patients, this means the opportunity to regain some control, maintain privacy and encourage a positive attitude towards treatment. 

Investing in scientific testing and development has allowed us to attain the highest levels of technical precision and clinical efficacy of our cold cap.

Paxman - chasing zero hair loss during chemotherapy.